Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro

被引:7
作者
Gu, Jian-Hong [1 ]
Liu, Jun-Dong [2 ]
Shen, Yan [1 ]
Liu, Zong-Ping [1 ]
机构
[1] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Peoples R China
[2] Jiangsu Polytech Coll Anim Husb & Vet, Taizhou 225300, Peoples R China
基金
中国国家自然科学基金;
关键词
Muscovy ducks; Osteoclasts; RANKL; Osteoprotegrin; Calcium; Phosphorus; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-RESORPTION; TNF FAMILY; INVOLVEMENT; MECHANISMS; APOPTOSIS; PROTEASE;
D O I
10.1016/j.tvjl.2008.03.006
中图分类号
S85 [动物医学(兽医学)];
学科分类号
090604 [动物药学];
摘要
The aim of this study was to determine whether receptor activator of nuclear factor NF-kappa B ligand (RANKL), osteoprotegerin (OPG) and a calcium:phosphorous (Ca:P) ratio of 2:1 could affect survival and activation of Muscovy duck osteoclasts (OCs). Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors. (B) 30 ng/ml soluble RANKL (sRANKL), (C) 30 ng/ml sRANKL and 10 ng/mL OPG, (D) 10 ng/mL OPG, (E) 50 ng/mL OPG, (F) 100 ng/mL OPG and (G) 30 ng/mL sRANKL, 6 mmol/L Ca and 3 mmol/L P. sRANKL promoted the survival Of OCs oil day 2. whereas the number of OCs decreased with addition of OPG in a dose-dependent manner. OPG and Ca:P (2:1) both inhibited OC survival induced by RANKL. RANKL stimulated bone resorption by OCs. whereas OPG, but not Ca:P (2:1). inhibited the activity of OCs induced by RANKL. RANKL promotes the survival and activation of OCs front Muscovy ducks, whereas OPG and. to it lesser extent. Ca:P (2:1) reduce the life Span and inhibited the activation of OCS induced by RANKL. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 28 条
[1]
Vascular endothelial growth factor receptors in osteoclast differentiation and function [J].
Aldridge, SE ;
Lennard, TWJ ;
Williams, JR ;
Birch, MA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (03) :793-798
[2]
RANK ligand [J].
Blair, J. M. ;
Zheng, Y. ;
Dunstan, C. R. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (06) :1077-1081
[3]
Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis [J].
Blair, JM ;
Zhou, H ;
Seibel, MJ ;
Dunstan, CR .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01) :41-49
[4]
RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons [J].
Boissy, P ;
Destaing, O ;
Jurdic, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (02) :340-346
[5]
Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin [J].
Bridgham, JT ;
Johnson, AL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 307 (04) :956-961
[6]
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[7]
CALCITONIN ALTERS BEHAVIOR OF ISOLATED OSTEOCLASTS [J].
CHAMBERS, TJ ;
MAGNUS, CJ .
JOURNAL OF PATHOLOGY, 1982, 136 (01) :27-39
[8]
The new bone biology: Pathologic, molecular, and clinical correlates [J].
Cohen, M. Michael, Jr. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (23) :2646-2706
[9]
Regulation of Osteoclast Formation and Function [J].
Duong L.T. ;
Rodan G.A. .
Reviews in Endocrine and Metabolic Disorders, 2001, 2 (1) :95-104
[10]
Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands [J].
Horowitz, MC ;
Xi, YG ;
Wilson, K ;
Kacena, MA .
CYTOKINE & GROWTH FACTOR REVIEWS, 2001, 12 (01) :9-18